Supplementary Table 1 - Gene Expression from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance

Supplementary Table 1 - Gene Expression from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance

<p>Gene Expression-RNAseq. Summary gene expression data of the individual tumors included in Fig. 5a-c.</p>

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Renzo Perales-Linares (17314863) (author)
مؤلفون آخرون:	Nektaria Maria Leli (17314866) (author), Hesham Mohei (17314869) (author), Silvia Beghi (17314872) (author), Osvaldo D. Rivera (17314875) (author), Nektarios Kostopoulos (17314878) (author), Andrea Giglio (17314881) (author), Subin S. George (17314884) (author), Mireia Uribe-Herranz (17314887) (author), Francesca Costabile (17314890) (author), Stefano Pierini (17314893) (author), Sergei Pustylnikov (17314896) (author), Giorgos Skoufos (14865857) (author), Yoseph Barash (15130157) (author), Artemis G. Hatzigeorgiou (17314899) (author), Constantinos Koumenis (14865905) (author), Amit Maity (17314902) (author), Michael T. Lotze (14937723) (author), Andrea Facciabene (17314905) (author)
منشور في:	2025
الموضوعات:	Cancer Tumor Biology Immuno-oncology Immunology Tumor resistance to immune response Immunotherapy Combination immunotherapy Progression, Invasion & Metastasis Tumor progression
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة

Supp. Figure 1 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
حسب: Renzo Perales-Linares (17314863)
منشور في: (2025)

Supp. Figure 2 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
حسب: Renzo Perales-Linares (17314863)
منشور في: (2025)

Supp. Figure 3 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
حسب: Renzo Perales-Linares (17314863)
منشور في: (2025)

Supp. Figure 4 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
حسب: Renzo Perales-Linares (17314863)
منشور في: (2025)

Supp. Figure 5 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
حسب: Renzo Perales-Linares (17314863)
منشور في: (2025)

Supp. Figure 6 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
حسب: Renzo Perales-Linares (17314863)
منشور في: (2025)

Figure S1 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
حسب: Xiaodong Shu (16721586)
منشور في: (2025)

Figure S2 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
حسب: Xiaodong Shu (16721586)
منشور في: (2025)

Figure S3 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
حسب: Xiaodong Shu (16721586)
منشور في: (2025)

Figure S4 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
حسب: Xiaodong Shu (16721586)
منشور في: (2025)

Figure S5 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
حسب: Xiaodong Shu (16721586)
منشور في: (2025)

Figure S6 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
حسب: Xiaodong Shu (16721586)
منشور في: (2025)

Figure S7 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
حسب: Xiaodong Shu (16721586)
منشور في: (2025)

Table S1-S9 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
حسب: Xiaodong Shu (16721586)
منشور في: (2025)

Supplementary Tables S2-13 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer
حسب: Francisco Hermida-Prado (14958909)
منشور في: (2025)

Supplementary Tables from MYC Overexpression Drives Immune Evasion in Hepatocellular Carcinoma That Is Reversible through Restoration of Proinflammatory Macrophages
حسب: Renumathy Dhanasekaran (14962092)
منشور في: (2025)

Supplementary Table1 from USP48 Stabilizes Gasdermin E to Promote Pyroptosis in Cancer
حسب: Yidan Ren (14845140)
منشور في: (2025)

Supplementary Table2 from USP48 Stabilizes Gasdermin E to Promote Pyroptosis in Cancer
حسب: Yidan Ren (14845140)
منشور في: (2025)

Supplementary Table3 from USP48 Stabilizes Gasdermin E to Promote Pyroptosis in Cancer
حسب: Yidan Ren (14845140)
منشور في: (2025)

Supplementary Table 7_Genes identified by differential expression analysis in pro vs non metastatic clones from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
حسب: Niccolò Roda (16437288)
منشور في: (2025)

Figure S.1 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
حسب: Xufeng Lu (14960724)
منشور في: (2025)

Figure S.2 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
حسب: Xufeng Lu (14960724)
منشور في: (2025)

Figure S.3 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
حسب: Xufeng Lu (14960724)
منشور في: (2025)

Figure S.4 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
حسب: Xufeng Lu (14960724)
منشور في: (2025)

Figure S.5 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
حسب: Xufeng Lu (14960724)
منشور في: (2025)

Figure S.6 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
حسب: Xufeng Lu (14960724)
منشور في: (2025)

Figure S.7 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
حسب: Xufeng Lu (14960724)
منشور في: (2025)

Figure S.8 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
حسب: Xufeng Lu (14960724)
منشور في: (2025)

Supplementary Table 6_Gene modules analysis_GO and curated pathways associated to gene modules from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
حسب: Niccolò Roda (16437288)
منشور في: (2025)

Supplementary Data from PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING–Type I Interferon Signaling in Glioblastoma
حسب: Isha Mondal (16721699)
منشور في: (2025)

Supplementary Figure S1 from An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer
حسب: Carlotta Antoniotti (15352506)
منشور في: (2025)

Supplementary Figure S2 from An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer
حسب: Carlotta Antoniotti (15352506)
منشور في: (2025)

Supplementary Figure S3 from An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer
حسب: Carlotta Antoniotti (15352506)
منشور في: (2025)

Supplementary Table 9_Pro metastatic pathways identified by differential expression singlePT setting from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
حسب: Niccolò Roda (16437288)
منشور في: (2025)

Figure 1 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
حسب: Massimiliano Mellone (14959419)
منشور في: (2025)

Figure 2 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
حسب: Massimiliano Mellone (14959419)
منشور في: (2025)

Figure 3 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
حسب: Massimiliano Mellone (14959419)
منشور في: (2025)

Figure 4 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
حسب: Massimiliano Mellone (14959419)
منشور في: (2025)

Figure 5 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
حسب: Massimiliano Mellone (14959419)
منشور في: (2025)

Figure 6 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
حسب: Massimiliano Mellone (14959419)
منشور في: (2025)

Cannot write session to /tmp/vufind_sessions/sess_g6fdodeeiqmhdij109qkq635p1